Literature DB >> 7194570

Determination of scrapie agent titer from incubation period measurements in hamsters.

S B Prusiner, S P Cochran, D E Downey, D F Groth.   

Abstract

Progress in studies on the scrapie agent has been hampered by the slow and tedious endpoint titration assays in rodents. A new assay based on incubation period measurements has been developed. The incubation period is defined as the time interval from inoculation to the onset of clinically detectable neurological illness or as the interval from inoculation to death. Both of these intervals or incubation periods are inversely proportional to the size of the dose injected intracerebrally into random bred weanling syrian hamsters. The incubation period was found to be a linear function of the logarithm of the inoculum size over a wide range of dosages (10(2) - 10(8) ID50 units). From these studies an equation relating the titer of the inoculum to the dilution of the sample and the length of the incubation period has been developed facilitating the use of a computerized record system. Validation of the assay was provided by comparing samples where the agent was measured both by endpoint titration and incubation period methods. Agreement between the 2 methods was generally within +/- 0.5 log10 ID50 units. In addition, no differences between the molecular properties of the agents from hamster and murine sources have been detected using primarily the incubation period method with the former and endpoint titration with the latter. The advantages of the incubation period assay are considerable with respect to time and economy.

Entities:  

Mesh:

Year:  1981        PMID: 7194570     DOI: 10.1007/978-1-4757-0495-2_35

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  In vitro generation of high-titer prions.

Authors:  Ronald A Shikiya; Jason C Bartz
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Design and construction of diverse mammalian prion strains.

Authors:  David W Colby; Kurt Giles; Giuseppe Legname; Holger Wille; Ilia V Baskakov; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

Review 3.  Prion Strain Diversity.

Authors:  Jason C Bartz
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

4.  Inactivation of prions by acidic sodium dodecyl sulfate.

Authors:  David Peretz; Surachai Supattapone; Kurt Giles; Julie Vergara; Yevgeniy Freyman; Pierre Lessard; Jiri G Safar; David V Glidden; Charles McCulloch; Hoang-Oanh B Nguyen; Michael Scott; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 5.  Vertebrate food products as a potential source of prion-like α-synuclein.

Authors:  Bryan Andrew Killinger; Viviane Labrie
Journal:  NPJ Parkinsons Dis       Date:  2017-11-24

6.  Oral transmissibility of prion disease is enhanced by binding to soil particles.

Authors:  Christopher J Johnson; Joel A Pedersen; Rick J Chappell; Debbie McKenzie; Judd M Aiken
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

7.  Prion infected meat-and-bone meal is still infectious after biodiesel production.

Authors:  Cathrin E Bruederle; Robert M Hnasko; Thomas Kraemer; Rafael A Garcia; Michael J Haas; William N Marmer; John Mark Carter
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

8.  Prions efficiently cross the intestinal barrier after oral administration: Study of the bioavailability, and cellular and tissue distribution in vivo.

Authors:  Akihiko Urayama; Luis Concha-Marambio; Uffaf Khan; Javiera Bravo-Alegria; Vineetkumar Kharat; Claudio Soto
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

9.  Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.

Authors:  Kohtaro Miyazawa; Hiroyuki Okada; Kentaro Masujin; Yoshifumi Iwamaru; Takashi Yokoyama
Journal:  Prion       Date:  2015       Impact factor: 3.931

10.  Independent amplification of co-infected long incubation period low conversion efficiency prion strains.

Authors:  Thomas E Eckland; Ronald A Shikiya; Jason C Bartz
Journal:  PLoS Pathog       Date:  2018-10-18       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.